Error: Could not add to watchlist. X
+ Watchlist

Progenics Pharmaceuticals Inc

PGNX:US
NASDAQ GS
6.81
USD
0.06
0.88%
As of 2:17 PM EDT 5/24/2017
Open
6.86
Day Range
6.76 - 6.92
Volume
302,853
Previous Close
6.87
52Wk Range
4.00 - 11.72
1 Yr Return
39.25%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
6.86
Day Range
6.76 - 6.92
Volume
302,853
Previous Close
6.87
52Wk Range
4.00 - 11.72
1 Yr Return
39.25%
YTD Return
-21.19%
Current P/E Ratio (TTM)
92.38
Earnings per Share (USD) (TTM)
0.07
Market Cap (m USD)
476.127
Shares Outstanding (m)
70.225
Price/Sales (TTM)
6.88
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.28%
% Price Change
+0.16%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
Address
1 World Trade Center
47th Floor, Suite J
New York, NY 10007
United States
Phone
1-646-975-2500
Show More